SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-23-050725
Filing Date
2023-06-22
Accepted
2023-06-22 08:14:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea180783-defa14a_virpaxpharm.htm DEFA14A 243677
2 GRAPHIC img_001.jpg GRAPHIC 2465
  Complete submission text file 0001213900-23-050725.txt   248277
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40064 | Film No.: 231031529
SIC: 2834 Pharmaceutical Preparations